Status:
UNKNOWN
Pretreatment Lymphocyte Monocyte Ratio on Outcome HCC Patients
Lead Sponsor:
Amany Aboalenen Amin
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
20-80 years
Brief Summary
To assess the prognostic role of pretreatment LMR in hepatocellular carcinoma(HCC).
Detailed Description
The exact molecular mechanisms responsible for the prognostic impact of lymphocyte monocyte ratio in Heatocellular carcinoma are unclear.It has been suggested that cross-talk between the inflammatory ...
Eligibility Criteria
Inclusion
- Patients with child A Hepatocellular carcinoma.
Exclusion
- Patients with child C Hepatocellular carcinoma.
- Patients with heart failure
Key Trial Info
Start Date :
April 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2020
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03869151
Start Date
April 5 2019
End Date
March 31 2020
Last Update
April 2 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.